Non-small cell lung cancer, the more common type, has a slightly better five-year survival rate of 9% compared to small cell lung cancer’s 5-year survival rate of 3% when diagnosed at a late stage. These general survival rates are based on those who receive an initial lung cancer diagn...
Stage 4 Lung Cancer Prognosis: What to Expect Stage 4 lung cancer is the most advanced type of lung cancer. Support groups, clinical trials, and a palliative care specialist can all help you navigate this advanced stage. Lung cancer is the third most commonly diagnosed cancer in the United S...
non-small cell lung cancerprognosismetastasismultivariate analysisObjective: To investigate the prognostic factors for stage IV non-small cell lung cancer (NSCLC) with distant metastasis and establish a reliable model of clinical prognostic index. Methods: From January 1990 to April 2005, 313 primary ...
The outcomes of thoracic surgery for patients with stage IV non–small-cell lung cancer (NSCLC) are controversial and uncertain. Patients and methods The National Cancer Institute's Surveillance, Epidemiology, and End Results was queried for patients with stage IV NSCLC, including those treated with...
Keywords: lung cancer prognosis; lung cancer stages; lung cancer stage classification; prognostic factors; TNM classification 学习笔记 1.首先从整个TNM分期委员会传递出来的信息是:TNM分期是一种肿瘤解剖学范围, 解剖学外仍然有很多因素(如patient-related...
non-small cell lung cancer CTC: circulating tumor cell HD-SCA: high-definition single cell assay CK: cytokeratin WBC: white blood cells PFS: progression-free OS: overall survival EpCAM: epithelial cell adhesion molecule cfDNA: cell free DNA AR-V7: androgen receptor splice variant ...
Tumor size affects survival in resected stage IA nonsmall cell lung cancer. Current definition of stage IA disease should be substaged into two separate stages. In patients with early-stage lung cancer and relatively good prognosis actual recurrence rate is more realistic than the actuarial recurrenc...
l cell lung cancer. VATS is an adequate oncological operation for stage I non-small cell lung cancer.VATS is an adequate oncological operation for stage I non-small cell lung cancer.This study was designed to determine the long-term prognosis of video-assisted thoracic surgery (VATS) vs. ...
non‐small cell lung carcinomaprognosistumor stagingBackground Even after curative resection, the prognosis of pathological stage I non-small cell lung cancer (NSCLC) can be heterogeneous, and the use of adjuvant chemotherapy in these patients is controversial. We aimed to identify the prognostic ...
Immunotherapy targeting PD-1/PD-L1 has revolutionized the treatment of extensive-stage small cell lung cancer (ES-SCLC). However, clinical trials suggest differential efficacy of anti-PD-1 agents and anti-PD-L1 agents in first-line treatment of ES-SCLC.